Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection
Clinical trial NCT02487030 · COMPLETED
Trial details
- NCT number
- NCT02487030
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-07
- Primary completion
- 2016-11-11
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.